Oregon Health and Science University, Department of Surgery, Portland.
Legacy Good Samaritan Medical Center, Portland. Oregon.
JAMA Surg. 2014 Sep;149(9):955-61. doi: 10.1001/jamasurg.2014.675.
Enhanced recovery after surgery (ERAS) colorectal programs have shown to be successful at reducing length of stay in many international and academic centers; however, their efficacy in a community hospital setting remains unclear.
To determine if favorable results could be reproduced in a community hospital setting using our ERAS program, which was developed using core ERAS guidelines with the goal of accelerated recovery while also addressing other important outcomes affecting patient experience and safety.
DESIGN, SETTING, AND PARTICIPANTS: Prospective study of ERAS program, a multidisciplinary effort involving anesthesia, preadmission staff, nursing, and surgery staff at a community hospital. The program was initiated in 2010 and was in full practice by 2011. We assessed practice patterns and patient outcomes for all elective colon and rectal resection cases performed in 2009 (prior to ERAS implementation), 2011, and 2012.
Laparoscopic approach, narcotic use, length of stay, 30-day readmission, ileus (defined as reinsertion of nasogastric tube), and intra-abdominal infection and association between colorectal cancer (CRC) diagnosis and these outcomes.
From 2009 to 2012, the use of laparoscopy increased from 57.4% to 88.8% (P < .001). Length of stay decreased significantly (6.7 days vs 3.7 days, P < .001), without an increase in 30-day readmission rate (17.6% vs 12.5%, P = .49). Use of patient-controlled narcotic analgesia and duration of use decreased (63.2% of patients vs 15%, P < .001; 67.8 hours vs 47.1 hours, P = .02). Ileus rate decreased from 13.2% to 2.5% (P = .02). Intra-abdominal infection decreased from 7.4% to 2.5% (P = .24). When comparing laparoscopic cases alone, similar results were observed. Following regression analysis, there were no statistically significant differences between CRC diagnosis and LOS, 30-day readmission rates, ileus, and intra-abdominal infection (all P's > .05). Length of stay reductions resulted in an estimated cost savings of $3202 per patient (2011) and $4803 per patient (2012).
Implementation of this patient care-directed enhanced recovery program is feasible in a community hospital setting, and it is associated with decreased LOS without increased readmission or morbidity, as well as significant decreases in narcotic use and cost. Improved outcomes are independent of the laparoscopic approach and CRC diagnosis.
重要性:加速康复外科(ERAS)结直肠方案已被证实可成功缩短许多国际和学术中心患者的住院时间;然而,其在社区医院环境中的疗效尚不清楚。
目的:确定在使用我们的 ERAS 方案的社区医院环境中是否可以获得有利的结果。该方案是使用 ERAS 核心指南制定的,旨在加速康复,同时解决影响患者体验和安全的其他重要结局。
设计、地点和参与者:对社区医院多学科努力的 ERAS 方案进行前瞻性研究,涉及麻醉、入院前工作人员、护理和手术人员。该方案于 2010 年启动,并于 2011 年全面实施。我们评估了 2009 年(在 ERAS 实施之前)、2011 年和 2012 年所有择期结肠和直肠切除术病例的实践模式和患者结局。
主要结果和措施:腹腔镜方法、阿片类药物使用、住院时间、30 天再入院、肠梗阻(定义为重新插入鼻胃管)、腹腔内感染以及结直肠癌(CRC)诊断与这些结局之间的关系。
结果:从 2009 年到 2012 年,腹腔镜使用率从 57.4%增加到 88.8%(P < .001)。住院时间显著缩短(6.7 天 vs 3.7 天,P < .001),30 天再入院率无增加(17.6% vs 12.5%,P = .49)。患者自控阿片类药物的使用和使用时间减少(63.2%的患者 vs 15%,P < .001;67.8 小时 vs 47.1 小时,P = .02)。肠梗阻发生率从 13.2%降至 2.5%(P = .02)。腹腔内感染从 7.4%降至 2.5%(P = .24)。单独比较腹腔镜病例时,观察到类似的结果。回归分析后,CRC 诊断与 LOS、30 天再入院率、肠梗阻和腹腔内感染之间无统计学显著差异(所有 P 值均 > .05)。住院时间的缩短导致每位患者估计节省 3202 美元(2011 年)和每位患者 4803 美元(2012 年)的成本。
结论和相关性:在社区医院环境中实施这种以患者为导向的增强恢复方案是可行的,与住院时间缩短相关,而不会增加再入院率或发病率,并且显著减少阿片类药物的使用和成本。改进的结果独立于腹腔镜方法和 CRC 诊断。